Larvol Delta - Annovis-Bio-Receives-Excellent-Safety-Rating-and-Positive-Recommendation-to-Continue-Phase-III-Trial-of-Buntanetap-for-Parkinsons-Disease-Patients-from-the-Independent-Data-and-Safety-Monitoring-Board-DSMB

Posiphen (buntanetap) - Annovis Bio

https://www.businesswire.com/news/home/20230620060989/en/Annovis-Bio-Receives-Excellent-Safety-Rating-and-Positive-Recommendation-to-Continue-Phase-III-Trial-of-Buntanetap-for-Parkinson%E2%80%99s-Disease-Patients-from-the-Independent-Data-and-Safety-Monitoring-Board-DSMB

Jun 20, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next